Clinical Trials Logo

Filter by:
NCT ID: NCT02834780 Completed - Clinical trials for Hepatocellular Carcinoma

Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma

Start date: December 28, 2016
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine the maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D) of H3B-6527, and to assess the safety, tolerability and pharmacokinetics of H3B-6527.

NCT ID: NCT02834728 Completed - Clinical trials for Frail Elderly People

Frail Elderly Subjects - Evaluation and Follow-Up

SAFES Cohort
Start date: March 2001
Phase: N/A
Study type: Observational

This was a prospective multicenter cohort study of elderly people admitted to medical wards via emergency departments. Subjects were followed up to 36 months. It aimed to study the inhospital pathways and adverse geriatric outcomes. In all, 1306 subjects were included : 85+/-5 years, and mainly women (65%).

NCT ID: NCT02834546 Completed - Clinical trials for Hepatocellular Carcinoma (HCC)

Correlation Between Sorafenib Plasma Concentrations, Toxicity and Disease Control Rate in Patients Treated by Sorafenib for Hepatocellular Carcinoma

ACTES
Start date: July 25, 2017
Phase:
Study type: Observational

The aim of this pilot study is to correlate the sorafenib plasma concentration to observed toxicity and to the disease control rate in 100 patients undergoing a palliative treatment of hepatocellular carcinoma (HCC). If some correlations are observed, we will consider planning a larger interventional study to adjust sorafenib daily dose to plasma concentration.

NCT ID: NCT02834494 Completed - Breast Neoplasms Clinical Trials

Assessment of Response to Neo-adjuvant Chemotherapy for Patients With a Locally Advanced Breast Cancer With 3D Elastography (Shear Wave),

NEO-ELASTO
Start date: February 22, 2016
Phase: N/A
Study type: Interventional

Assess the accuracy of the sequential measurements by 3D Shear Wave Elastography (SWE) for predicting histological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.

NCT ID: NCT02834351 Completed - Clinical trials for Peripheral Artery Disease

Tissue Lesions in Exercise Related Ischemia

SARTORIUS
Start date: July 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effect of muscle ischemia during claudication on mitochondrial function. Comparison to patients with arterial disease but absence of lower limb claudication (Cardiac group) feasibility study.

NCT ID: NCT02834273 Completed - Stroke Clinical Trials

Patient Education Following a Stroke

EPIC
Start date: June 2013
Phase: N/A
Study type: Interventional

The rapid diagnosis and treatment of acute ischemic stroke are critical in the reduction of morbidity, disability and stroke associated mortality Under-education about stroke may prevent people from recognizing symptoms early enough to seek immediate care. The studies reported on stroke patients managed in stroke center have shown that 39-42% of patients could not name any symptoms of stroke and 36% to 43% no risk factor of stroke. The stroke patients are therefore a population at high risk for neurological events and cardiac vascular recurrence. However, no studies have evaluated the interest of the development of therapeutic workshops in stroke unit to educate patients about symptoms suggestive of stroke, risk factors and what to do in cases of stroke. Investigators assume that the setting up of a therapeutic education workshop in the stroke unit may allow a better understanding of the symptoms, risk factors and what to do following stroke. So there is a direct benefit to the patient represented by a better knowledge of stroke (warning signs, risk factors, what to do), improved treatment compliance and reduced risk of recurrence. More generally, there is a real benefit to promote these messages to the public through the patient and his relatives

NCT ID: NCT02834260 Completed - Keratoconus Clinical Trials

Immunosuppression During Penetrating Keratoplasty, Using a Subconjunctival Implant Releasing Dexamethasone : Tolerance and Safety Pilot Study

IDEXACOR
Start date: January 10, 2017
Phase: Phase 2
Study type: Interventional

Immune rejection episodes after penetrating keratoplasty occur in 30% of patients and constitute one of the main factors reducing graft survival. They mainly occur during the first 18 months. Prevention usually relies on a topical treatment with dexamethasone or prednisolone for standard risk patients. Eye drops are instilled three times a day during at least 3 months then tapered. OZURDEX is an absorbable small implant that releases a total of 700 micrograms dexamethasone during several months. It is indicated for intravitreal injection to treat macular edema. The investigators hypothesized that this implant could be used after subconjunctival injection during corneal graft, to prevent immune rejection and avoid repeated eyedrop instillations.

NCT ID: NCT02834195 Completed - Cerebral Palsy Clinical Trials

Types of Upper Limb and Hand in Patients With Cerebral Palsy

CLASS-MS
Start date: June 2013
Phase: N/A
Study type: Observational

Cerebral palsy (CP) has been defined as "a group of permanent disorders of the development of movement and posture causing activity limitation(s) that are attributed to non-progressive disturbances that occurred in the developing fetal or infant brain". Investigators previously developed two classification systems, one for the upper limb and one for the hand, based on 100 films of patients with cerebral palsy. Separate classifications were developed following an initial study in which investigators found no correlations between upper limb and hand patterns, meaning that specific upper limb patterns are not always associated with specific hand patterns. Thumb patterns were not included in these classifications since robust classifications already exist, moreover thumb patterns are independent from hand patterns. The aim is to evaluate the inter- and intra-rater reliability of two previously developed classifications of upper limb and hand patterns.

NCT ID: NCT02834156 Completed - Clinical trials for Hematological Malignancies

Impact of Child Positioning on Pain During a Lumbar Puncture

PHIPA-PEPL
Start date: June 30, 2015
Phase: N/A
Study type: Interventional

This protocol is a pilot study on standard care. The main goal is to assess the impact of positioning on lumbar puncture process especially on pain sensitivity in children. It's a prospective, monocentric, randomized, open-label, cross-over study. Inclusion period is one year, and number of inclusions forecasted is about 30. Each patient will have one LP in a seated position and one in a lying position.

NCT ID: NCT02834143 Completed - Stroke Clinical Trials

Evaluation of Diagnostic Criteria for Chronic Critical Limb Ischemia

CRIMI
Start date: June 13, 2014
Phase: N/A
Study type: Observational

Chronic critical limb ischemia (CCI) is the most severe clinical form of occlusive arterial disease. Its prognosis is terrible, mortality estimated at 50% in five years. However there are no recent epidemiological data on morbidity and mortality of critical ischemia. Moreover, the diagnostic criteria of the ICC associate clinical and hemodynamic criteria and are not subject to a clear consensus. Investigators propose to evaluate the validated diagnostic criteria (TASC VALMI, European working group) in a population of severe ischemia in patients in order to offer relevant simple and reproducible criteria. Secondly Investigators propose to monitor the medium and long term evolution of these patients ICC defined to clarify the prognosis. diagnostic criteria of the different societies: - TASC: Transatlantic criteria: very characteristic pain, wound optional, variable hemodynamic criteria as the presence of a wound or not - VALMI: French criteria derived vascular medical college: characteristic pain, sore, hemodynamic reproducible, reliable criteria - European working group: European definition of criteria, including a characteristic pain, requires no wound, different hemodynamic criteria of 2 others.